TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 1 | -2 | -4 | -3 | -20 | -21 | -8 |
| P | %wins | 50 | 50 | 50 | 50 | 0 | 50 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/14/11 12:25 | 3/10/11 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Scheer David | CT | D | P.m | 153 | 15.26 | 0 | 10 | 1 | 1,290 | D | 20 | 30 | 5 | 6 | 1 | -1 | 0 | 6 | 10 | -4 | 4 | ||||
4/15/10 16:00 | 4/14/10 | TNGN | Tengion Inc | Health | BioPrd | Biological Products, (No Diag | Scheer David | PA | D | P.d | 100 | 5.00 | 1 | 20 | 12 | 188 | I | 3 | -3 | -14 | -16 | -36 | -45 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |